AMANDA OBRIEN: Open Payments
NPI 1568157907 · FRANKFORT, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,360 in 51 payments from 17 companies in 2025. Trend: 2023 $991 · 2024 $1,170 · 2025 $1,360
Food & beverage: $1,360
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $286 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $230 |
| Janssen Pharmaceuticals, Inc | 6 | $156 |
| Alkermes, Inc. | 4 | $104 |
| Neurocrine BioSciences, Inc. | 3 | $91 |
| E.R. Squibb & Sons, L.L.C. | 4 | $90 |
| Axsome Therapeutics, Inc. | 3 | $80 |
| ABBVIE INC. | 2 | $57 |
| Tris Pharma Inc | 2 | $48 |
| Teva Pharmaceuticals USA, Inc. | 2 | $47 |
Products named: CAPLYTA, ABILIFY MAINTENA, REXULTI, SPRAVATO, INGREZZA, Auvelity, ARISTADA, COBENFY.
Industry payments across IL — which companies pay providers there.
